The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review
Author(s)
AlRabayah A1, Puntscher S2, Al Sayah F3, Stolk E4, Simon J5, Drummond M6, Siebert U7
1King Hussein Cancer Center, Amman, Jordan, 2UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria, 3School of Public Health, University of Alberta, Edmonton, AB, Canada, 4EuroQol Research Foundation, Rotterdam, Netherlands, 5Medical University of Vienna, Vienna, Austria, 6University of York, York, YOR, UK, 7UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria. ONCOTYROL - Center for Personalized Cancer Medicine, Innsbruck, Austria. Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, MA, USA
Presentation Documents
OBJECTIVES:
The EuroQol EQ-5D is the most commonly used preference-based measure of health-related quality of life. There is limited knowledge about the use of EQ-5D in the Middle East and North Africa (MENA) region. This study aimed to systematically review, summarize, and synthesize all published literature on the use of EQ-5D in various applications in this region.METHODS:
A systematic literature review was conducted covering the period up to May 2021, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies using any version of EQ-5D in adults or youth in the MENA region were included. Pilot studies, guidelines, study protocols, reviews were excluded. Four main databases were searched: PubMed, Cochrane, PsycINFO, and CINAHL. The primary outcomes were clinical area, EQ-5D utility index values, study design, population, and reference value set used. Title/abstract screening was conducted independently by two reviewers to assess eligibility for inclusion. Two researchers will complete the full text screening and will extract data using a standardized data extraction form. A third reviewer will check it and will review studies with uncertainty, and any disagreements will be resolved by discussion.RESULTS: A first extraction from the four databases resulted in a total of 13,498 references. After removing duplicates 12,218 references were considered for the title/abstract screening. 118 records were included for full-text review.
CONCLUSIONS:
CONCLUSION: The review results will be finalized by the time of the conferenceConference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
PCR232
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes, Stated Preference & Patient Satisfaction
Disease
No Additional Disease & Conditions/Specialized Treatment Areas